Monday, October 5, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleSeeking Alpha· July 27, 2026

Baker Hughes targets Horizon 2 IET orders above $45B as it forecasts $27.35B 2026 revenue and integrates Chart

View original at seekingalpha.com
Baker Hughes targets Horizon 2 IET orders above $45B as it forecasts $27.35B 2026 revenue and integrates Chart Earnings Call Insights: Baker Hughes (BKR) Q2 2026 MANAGEMENT VIEW * Chairman, President & CEO Lorenzo Simonelli framed Q2 as a quarter where “disciplined execution and the strength of our diversified portfoli…
Opening lines of the source · Seeking Alpha · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Q3 2026 guidance is company revenue of $6.87 billion and adjusted EBITDA of $1.205 billion, assuming Middle East activity remains broadly unchanged through year-end

    60% confidence
  • Asked about the drivers of record IET orders and margins on recent orders

    60% confidence
  • Baker Hughes is not providing Chart segment guidance today and will provide updated guidance ahead of Q3 earnings

    60% confidence
  • Uncertainty centers on project timing, local supply chains, Gas Tech equipment backlog conversion, and the aeroderivative supply chain; free cash strength reflected milestone and advanced payments, with working capital driving quarter-to-quarter variability

    60% confidence
  • GAAP diluted EPS was $0.68; excluding $0.04 of adjusting items, adjusted diluted EPS was $0.64

    60% confidence
  • OFSE revenue was $3.45 billion, EBITDA $605 million, margin 17.5%, a significantly stronger-than-anticipated quarter despite Middle East disruptions

    60% confidence
  • Data centers are one of the clearest near-term commercial opportunities with Chart, alongside actionable gas infrastructure opportunities across hydrogen, helium, CO2, nitrogen, oxygen, and longer-term adjacencies in space, geothermal and mining

    60% confidence
  • Chart will operate as Baker Hughes' third reporting segment with integration driven through 18 work streams

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,340 source documents archived
Query this data → isubstrate.com